Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Symptoms improved within first week: FDA approves new ADHD drug for children, adults

Simtriyo, the first approved ADHD drug to inhibit norepinephrine, dopamine and serotonin reuptake, improved symptoms within a week; US launch depends on controlled-substance classification, and it is not yet available in Israel

Symptoms improved within first week: FDA approves new ADHD drug for children, adults

We haven't written up this one. Ynetnews Culture has the full story — the link below goes straight to it.

Read the original at ynetnews.com →

More in Health & Medicine

More from Sunday 2 August →